Trial intelligence / Profile preview

Axumin PET/CT in Gynecological Cancers

NCT03349463Phase 4Unknown

Start
Nov 2018
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of fluciclovine f 18 in Cervical Cancer (CC), endometrial cancer (EC), ovarian epithelial cancer. Status: unknown.

02

Drugs

fluciclovine f 18
03

Conditions

Cervical Cancer (CC)endometrial cancer (EC)ovarian epithelial cancer

Beyond the preview

Go deeper on NCT03349463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03349463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call